Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-12 7:57 pm Sale |
2025-03-10 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,556,369 4.500% |
-229,202 (-12.84%) |
Filing History |
| 2025-03-03 4:01 pm Unchanged |
2025-02-27 | 13D | Disc Medicine, Inc. IRON |
AI DMI LLC | 3,762,507 10.800% |
0 (Unchanged) |
Filing History |
| 2025-02-14 07:50 am Sale |
2024-12-31 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 983,500 3.300% |
-812,235 (-45.23%) |
Filing History |
| 2025-02-12 09:08 am Sale |
2024-12-31 | 13G | Disc Medicine, Inc. IRON |
FMR CORP | 1,866,248 6.300% |
-300,571 (-13.87%) |
Filing History |
| 2025-02-10 10:25 am Sale |
2024-12-31 | 13G | Disc Medicine, Inc. IRON |
WELLINGTON MANAGEMENT CO LLP | 1,395,405 4.700% |
-444,821 (-24.17%) |
Filing History |
| 2024-11-14 5:44 pm Purchase |
2024-09-30 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 1,795,735 6.000% |
463,190 (+34.76%) |
Filing History |
| 2024-11-14 4:33 pm Sale |
2024-09-30 | 13G | Disc Medicine, Inc. IRON |
Paradigm BioCapital Advisors LP | 1,497,720 5.040% |
-888,137 (-37.23%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Disc Medicine, Inc. IRON |
BLACKROCK INC BLK |
1,851,171 6.200% |
0 (Unchanged) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Disc Medicine, Inc. IRON |
WELLINGTON MANAGEMENT CO LLP | 1,840,226 6.190% |
1,840,226 (New Position) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Disc Medicine, Inc. IRON |
BLACKROCK INC BLK |
1,851,171 6.200% |
1,851,171 (New Position) |
Filing History |
| 2024-06-25 10:06 am Purchase |
2024-06-17 | 13G | Disc Medicine, Inc. IRON |
Frazier Life Sciences Public Fund, L.P. | 1,754,834 5.900% |
1,754,834 (New Position) |
Filing History |
| 2024-06-20 5:15 pm Purchase |
2024-06-17 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,785,571 6.000% |
83,334 (+4.90%) |
Filing History |
| 2024-06-20 4:01 pm Purchase |
2024-06-17 | 13D | Disc Medicine, Inc. IRON |
AI DMI LLC | 3,762,507 12.600% |
416,667 (+12.45%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Disc Medicine, Inc. IRON |
Paradigm BioCapital Advisors LP | 2,385,857 9.900% |
1,149,939 (+93.04%) |
Filing History |
| 2024-02-13 6:51 pm Sale |
2023-12-31 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 1,332,545 5.500% |
-658,369 (-33.07%) |
Filing History |
| 2024-02-09 08:50 am Purchase |
2024-02-08 | 13G | Disc Medicine, Inc. IRON |
FMR CORP | 2,166,819 8.975% |
24,095 (+1.12%) |
Filing History |
| 2024-02-07 07:24 am Sale |
2023-12-31 | 13G | Disc Medicine, Inc. IRON |
ADAGE CAPITAL PARTNERS GP LLC | 750,000 3.110% |
-412,624 (-35.49%) |
Filing History |
| 2024-01-25 4:38 pm Sale |
2024-01-23 | 13D | Disc Medicine, Inc. IRON |
Atlas Venture Fund X L.P. | 1,402,186 5.800% |
-191,599 (-12.02%) |
Filing History |
| 2023-12-15 4:48 pm Sale |
2023-12-13 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,702,237 7.100% |
-567,400 (-25.00%) |
Filing History |
| 2023-11-13 06:46 am Purchase |
2023-11-09 | 13D | Disc Medicine, Inc. IRON |
AI DMI LLC | 3,345,840 13.740% |
204,081 (+6.50%) |
Filing History |